Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Palliative Care

Edition
Latest

30-Second Takeaway

  • EHR-derived predictors can modestly stratify mortality risk in nursing home residents with dementia.
  • A co-designed, needs-based ILD referral tool (PaCT-ILD) provides explicit triggers but needs evaluation.
  • Current randomized evidence does not support routine adoption of care robots; benefits are low-certainty.

Latest - Week ending July 4, 2026

Five recent papers on prognostication, referral tools, family experience, hospice quality, and care robots relevant to palliative care practice

EHR predictors modestly discriminate mortality in nursing home residents with dementia

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATIONJul 3, 2026

In 922 Australian nursing home residents with moderate–severe dementia, five EHR-derived predictors were retained: age, male sex, oral intake assistance, baseline weight, and 6-month weight change. The model had modest discrimination (apparent c-statistic 0.64, optimism-corrected 0.61) and acceptable calibration (optimism-corrected slope 0.82). Authors propose these routinely collected variables could support anticipatory care planning if externally validated. Apply findings only to similar nursing home populations and avoid overreliance on a single model without local validation.

PaCT-ILD: a co-designed one-page referral tool for fibrosing ILD

ANNALS OF THE AMERICAN THORACIC SOCIETYJun 30, 2026

Using international surveys, interviews, and co-design workshops, investigators developed PaCT-ILD, a one-page clinician tool with five domains and three referral thresholds. Prioritized triggers include distressing symptoms, worsening quality of life, psychosocial distress, patient or caregiver request, and recurrent hospitalizations. The tool documents reasons for non-referral and prompts revisiting palliative care at future visits. Effectiveness, feasibility, and acceptability remain untested and should be evaluated before routine implementation.

Families report high involvement and satisfaction after precision-medicine treatment recommendations

NPJ GENOMIC MEDICINEJul 4, 2026

Among families in the PRISM pediatric precision medicine trial, most expected benefits and a recommendation at enrollment. Seventy percent of parents received a treatment recommendation, half recalled it, and parents reported high involvement (93/100) and satisfaction (95/100) in decisions. Receiving a recommendation was not associated with greater trial regret (p>0.05). These findings apply to families of children with poor-prognosis cancers in similar trial settings, not general pediatric oncology care.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Use EHR predictors cautiously; validate locally before informing individual care decisions.
  • Consider PaCT-ILD as a conversation aid, not a mandate, until feasibility and outcome data emerge.
  • Discuss care-robot trials as adjunctive and experimental; avoid replacing human-delivered palliative tasks.